MK-801 inhibits methamphetamine-induced conditioned place preference and behavioral sensitization to apomorphine in mice

Brain Research Bulletin

Volumn 44, Issue 3, 1997, Pages 221-227

  Kim, Hack Seang ^a   Jang, Choon Gon ^b  

^a Chungbuk National University   (South Korea)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Climbing behavior; Conditioned place preference; Dopamine; Methamphetamine; MK 801; N Methyl D aspartate Receptor; Sensitization

Indexed keywords

DIZOCILPINE; METHAMPHETAMINE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR MODIFICATION; CLIMBING; CONDITIONING; DRUG EFFECT; DRUG RECEPTOR BINDING; EXCITATORY POSTSYNAPTIC POTENTIAL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION;

ANIMALS; APOMORPHINE; BEHAVIOR, ANIMAL; CONDITIONING (PSYCHOLOGY); DIZOCILPINE MALEATE; DOPAMINE AGENTS; DOPAMINE AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; MALE; METHAMPHETAMINE; MICE; MICE, INBRED ICR; MOTOR ACTIVITY; SENSITIVITY AND SPECIFICITY;

EID: 0030852407     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(97)00093-2     Document Type: Article

References (53)

1. Acquas, E.; Carboni, E.; Leone, P.; Di Chiara, G. SCH 23390 blocks drug-conditioned place-preference and place-aversion: Anhedonia (lack of reward) or apathy (lack of motivation) after dopamine-receptor blockade? Psychopharmacology (Berlin) 99:151-155; 1989.
2. Aulisi, E. P.; Hoebel, B. G. Rewarding effects of amphetamine and cocaine in the nucleus accumbens and block by flupenthixol. Soc. Neurosci. Abstr. 36:121; 1983.
3. Bartoletti, M.; Gaiardi, M.; Gubellini, C.; Babbini, M. Further evidence for a motility substitution test as a tool to detect the narcotic character of new drugs in rats. Neuropharmacology 22:177-181; 1983.
4. Bhargava, H. N. Cyclo (Leucylglycine) inhibits the development of morphine induced analgesic tolerance and dopamine receptor supersensitivity in rat. Life Sci. 27:117-123; 1980.
5. Burns, L. H.; Everitt, B. J.; Kelley, A. E.; Robbing, T. W. Glutamatedopamine interactions in the ventral striatum: Role in locomotor activity and responding with conditioned reinforcement. Psychopharmacology (Berlin) 115:516-528; 1994.
6. Carr, G.; White, N. M. Conditioned place preference from intra-accumbens but not intra-caudate amphetamine injections. Life Sci. 33:2551-2557; 1983.
7. Carr, G.; White, N. M. Anatomical dissociation of amphetamine's rewarding and aversive effects: An intracranial microinjection study. Psychopharmacology (Berlin) 89:340-346; 1986.
8. Carlsson, M.; Carlsson, A. The NMDA antagonist MK801 causes marked locomotor stimulation in monoamine-depleted mice. J. Neural Transm. 75:221-226; 1989.
9. Cheramy, A.; Romo, R.; Godeheu, G.; Baruch, P.; Glowinski, J. In vivo presynaptic control of dopamine release in the cat caudate nucleus - II. Facilitatory or inhibitory influence of L-glutamate. Neuroscience 19:1081-1090; 1986.
10. Clineschmidt, B. V.; Martin, G. E.; Bunting, P. R.; Papp, N. L. Central sympathomimetic activity of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cycloheptin-5,10-imine (MK801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties. Drug Dev. Res. 2:135-144; 1982.
11. Costentin, J.; Protais, P.; Schwartz, J. C. Rapid and dissociated changes in sensitivities of different dopamine receptors in mouse brain. Nature 257:405-407; 1975.
12. D'Aquila, P. S.; Sias, A.; Gessa, G. L.; Serra, G. The NMDA receptor antagonist MK-801 prevents imipramine-induced supersensitivity to quinpirole. Eur. J. Pharmacol. 224:199-202; 1992.
13. Dimpfel, W.; Spuler, M. Dizocilpine (MK-801), ketamine and phencyclidine: Low doses affect brain field potentials in the freely moving rat in the same way as activation of dopaminergic transmission. Psychopharmacology (Berlin) 101:317-323; 1990.
14. Druhan, J. P.; Jakob, A.; Stewart, J. The development of behavioral sensitization to apomorphine is blocked by MK-801. Eur. J. Pharmacol. 243:73-77; 1993.
15. Ellinwood, E. H., Jr. Amphetamines/anorectic. In: Dupont, R. L.; Goldstein, A.; O'Donnell, J., eds. Handbook on drug abuse. Washington, DC: National Institute on Drug Abuse, U.S. Government Printing Office; 1979:221-231.
16. Ettenberg, A.; Pettit, H. O.; Bloom, F. E.; Koob, G. F. Heroin and cocaine intravenous self-administration in rats: Mediation by separate neural systems. Psychopharmacology (Berlin) 78:204-209; 1982.
17. Fischman, M. W. Cocaine and amphetamines. In: Melzer, H. Y., ed. Psychopharmacology: The third generation of progress. New York: Raven Press; 1987:1543-1553.
18. Gilbert, D.; Cooper, S. J. Beta-phenylethylamine-, d-amphetamine-and l-amphetamine-induced place preference conditioning in rats. Eur. J. Pharmacol. 95:311-314; 1983.
19. Henry, D. J.; White, F. J. Repeated cocaine administration causes persistent enhancement of D1 dopamine receptor sensitivity within the rat nucleus accumbens. J. Pharmacol. Exp. Ther. 258:882-890; 1991.
20. Huffman, D. C. The noncompetitive NMDA antagonist MK-801 fails to block amphetamine-induced place conditioning in rats. Pharmacol. Biochem. Behav. 47:907-912; 1994.
21. Karler, R.; Calder, S. D.; Chaudhry, I. A.; Turkanis, S. A. Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801. Life Sci. 45:599-606; 1989.
22. Kelley, A. E.; Throne, L. C. NMDA receptors mediate the behavioral effects of amphetamine infused into the nucleus accumbens. Brain Res. Bull. 29:247-254; 1992.
23. Kim, H. S.; Jang, C. G.; Oh, K. W.; Seong, Y. H.; Rheu, H. M.; Cho, D. H.; Kang, S. Y. Effects of ginseng total saponin on cocaine induced hyperactivity and conditioned place preference in mice. Pharmacol. Biochem. Behav. 53:185-190; 1996.
24. Kim, H. S.; Kang, J. G.; Rheu, H. M.; Cho, D. H.; Oh, K. W. Blockade by ginseng total saponin of the development of methamphetamine reverse tolerance and dopamine receptor supersensitivity in mice. Planta Med. 61:22-25; 1995.
25. Kim, H. S.; Park, W. K. Nitric oxide mediation of cocaine-induced dopaminergic behaviors: Ambulation-accelerating activity, reverse tolerance and conditioned place preference in mice, J. Pharmacol. Exp. Ther. 275:551-557; 1995.
26. Kim, H. S.; Park, W. K.; Jang, C. G.; Oh, S. K. Inhibition by MK-801 of cocaine-induced sensitization, conditioned place preference and dopamine receptor supersensitivity in mice. Brain Res. Bull. 40:201-207; 1996.
27. Kim, H. S.; Rhee, G. S.; Jung, J. Y.; Lee, J. H.; Jang, C. G.; Park, W. K. Inhibition by noncompetitive NMDA receptor antagonists of apomorphine-induced climbing behavior in mice. Life Sci. 58:1397-1402; 1996.
28. Klawans, H. L.; Margolin, O. J. Amphetamine-induced dopaminergic hypersensitivity in guinea pigs. Arch. Gen. Psychiatry 32:725-732; 1975.
29. Koob, G. F.; Bloom, F. E. Cellular and molecular mechanisms of drug dependence. Science 242:715-723; 1988.
30. Krebs, M. O.; Desce, J. M.; Kemel, M. L.; Gauchy, C.; Godeheu, G.; Cheramy, A.; Glowinski, J. Glutamatergic control of dopamine release in the rat striatum: Evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic nerve terminals. J. Neurochem. 56:81-85; 1991.
31. Kuribara, H.; Asami, T.; Ida, I.; Tadokoro, S. Characteristics of the ambulation-increasing effects of the noncompetitive NMDA antagonist MK-801 in mice: Assessment by the coadministration with central-acting drugs. Jpn. J. Pharmacol. 58:11-18; 1992.
32. Kuribara, H.; Tadokoro, S. Circadian variation in methamphetamine-and apomorphine-induced increase in ambulatory activity in mice. Pharmacol. Biochem. Behav. 17:1251-1256; 1982.
33. Lannes, B.; Micheletti, G.; Warter, J. M.; Kempf, E.; Scala, G. D. Behavioral, pharmacological and biochemical effects of acute and chronic administration of ketamine in the rat. Neurosci. Lett. 128:177-181; 1991.
34. Layer, R. T.; Kaddis, F. G.; Wallace, L. J. The NMDA receptor antagonist MK-801 elicits conditioned place preference in rats. Pharmacol. Biochem. Behav. 44:245-273; 1993.
35. Layer, R. T.; Uretski, N. J.; Wallace, L. J. Effects of the AMPA/ kainate receptor antagonist DNQX in the nucleus accumbens on drug-induced conditioned place preference. Brain Res. 617:267-273; 1993.
36. Leone, P.; Dichiara, G. Blockade of D-1 receptors by SCH 23390 antagonizes morphine- and amphetamine-induced place preference conditioning. Eur. J. Pharmacol. 135:251-254; 1987.
37. Moore, K. E.; Chiuch, C. C.; Zelole, G. Release of neurotransmitters from the brain in vivo by amphetamine, methylphenidate and cocaine. In: Ellinwood, E. H., Jr; Kilbey, M. M., eds. Advances in behavioral biology, vol. 21. New York: Plenum Press; 1977:143-160.
38. Mucha, R. F.; Van der Kooy, D.; O'Shaughnessy, M.; Bucenieks, P. Drug reinforcement studied by the use of place conditioning in rat. Brain Res. 243:91-105; 1982.
39. Nestler, E. J. Molecular mechanisms of drug addiction. J. Neurosci. 12:2439-2450; 1992.
40. Protais, P.; Costentin, J.; Schwartz, J. C. Climbing behavior induced by apomorphine in mice: A simple test for the study of dopamine receptors in striatum. Psychopharmacology (Berlin) 50:1-6; 1976.
41. Pulvirenti, L.; Swerdlow, N. R.; Koob, G. F. Microinjection of a glutamate antagonist into the nucleus accumbens reduces psychostimulant locomotion in rats. Neurosci. Lett. 103:213-218; 1989.
42. Pulvirenti, L.; Swerdlow, N. R.; Koob, G. F. Nucleus accumbens NMDA antagonist decreases locomotor activity produced by cocaine, heroin, or accumbens dopamine, but not caffeine. Pharmacol. Biochem. Behav. 40:841-845; 1991.
43. Raffa, R. B.; Ortegon, M. E.; Robisch, D. M.; Martin, G. E. In vivo demonstration of enhancement of MK801 by L-glutamate. Life Sci. 44:1593-1599; 1989.
44. Robinson, T.; Becker, J. Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis. Brain Res. Rev. 11:157-198; 1986.
45. Sala, M.; Braida, D.; Calcaterra, P.; Leone, M. P.; Gori, E. Dose-dependent conditioned place preference produced by etonitazene and morphine. Eur. J. Pharmacol. 217:37-41; 1992.
46. Serra, G.; Collu, M.; D'Aquila, P. S.; DeMontis, M. G.; Gessa, G. L. Possible role of dopamine D1 receptor in the behavioral supersensitivity to dopamine agonist induced by chronic treatment with antidepressants. Brain Res. 527:234-243; 1990.
47. Smith, A. D.; Bolam, J. P. The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurons. Trends Neurosci. 13:259-265; 1990.
48. Spyraki, C.; Fibiger, H. C.; Phillips, A. G. Dopaminergic substrates of amphetamine-induced place preference conditioning. Brain Res. 253:185-193; 1982.
49. Trazon, D. B.; Suzuki, T.; Misawa, M.; Watanabe, S. Methylxanthines (caffeine and theophylline) blocked methamphetamine-induced condi-tioned place preference in mice but enhanced that induced by cocaine. Ann NY Acad. Sci. 654:531-533; 1992.
50. Trujillo, A. K.; Akil, H. Inhibition of morphine tolerance and dependence by NMDA receptor antagonist MK-801. Science 251:85-87; 1991.
51. Wise, R. A.; Bozarth, M. A. A psychomotor theory of addiction. Psychol. Rev. 4:469-492; 1987.
52. Wise, R. A.; Rompre, P. P. Brain dopamine and reward. Annu. Rev. Psychol. 40:191-225; 1989.
53. Wolf, M. E.; Khansa, M. R. Repeated administration of MK-801 produce sensitization to its own locomotor stimulant effect but blocks sensitization to amphetamine. Brain Res. 562:164-168; 1991.